Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALB.L Regulatory News (ALB)

  • There is currently no data for ALB

Final Results

20 Nov 2008 07:00

RNS Number : 5368I
Albany Capital PLC
20 November 2008
Β 

ο»Ώ

Embargoed Release:Β 07:00hrsΒ Thursday 20thΒ November 2008

AlbanyΒ Capital plc

("AlbanyΒ Capital" or "the Company")

Preliminary Results

for the year endedΒ 30 September 2008

Albany Capital (ticker:Β ALB.L) is pleased to announceΒ unauditedΒ preliminary results for the year endedΒ 30 September 2008. TheΒ preliminary announcementΒ hasΒ been prepared in accordance with the requirements of IFRS 1 "First Time Adoption of International Financial Reporting Standards".Β 

Summary of results

Investment strategy delivers growth from core portfolio:

Well established China-based companies with good profit records

Both China Food Company plc and Sorbic International plc have delivered good profits growth and strong cash flow

Companies are well positioned in their respective markets to deliver further significant growthΒ once they have completed build of new production capacity over next twelve months

ChinaΒ investment portfolioΒ had a market value of Β£10.2 million at year endΒ against a cost Β£8.4m resulting in a fair value gain of Β£1.8m for the year

ChinaΒ investment portfolio represented 65% of the company's Net Assets at year endΒ and 82% of the total investment portfolio value at year end

NonΒ core investment portfolio had a market value of Β£2.2 million at year endΒ resulting in aΒ fair value loss of Β£2.6mΒ for the year

Retained lossΒ for the year endedΒ 30 September 2008Β of Β£847,674Β (30 September 2007: Β£114,250)Β Β Β 

Net assets per share atΒ 30 September 2008Β ofΒ 49.4Β pence per shareΒ (30 September 2007:Β 51.1 pence per share)

Cash reserves atΒ 30 September 2008Β of Β£2.8 millionΒ (30 September 2007: Β£10.5 million)

Commenting, John McLean, Chairman ofΒ AlbanyΒ Capital said:

"Since movingΒ AlbanyΒ onto a new investment strategyΒ we now have core holdings in companies with established trading records which are also very cash generative and well placed to benefit from future growth. Albany's core investments are on track to deliver further growth and it alsoΒ remains well placed with the cash resources toΒ makeΒ new investments."

Enquiries: www.albanycapital.co.uk

AlbanyΒ Capital , John McLean, Chairman

tel: +44 (0)7768 031454

WH Ireland,Β James Joyce/ Sarang Shah

tel: +44 (0) 20 7220 1666

Hansard Group,Β John Bick

tel: +44 (0)7872 061007

Chairman's Statement

Overview

I am pleased to report to shareholders on a successful year forΒ AlbanyΒ in which the Company has benefited from its first full year under the new investment strategy of investing in profitable and cash-generative growth companies which are based inΒ China. They are also positioned to benefit from the forecast growth inΒ China's domestic consumer sectors which is explained in more detail later. It is clear to your board that the investments made since December 2007 are in companies with strong profits records, good cash generation records and significant growth potential in their respective markets.

In the year endedΒ 30 September 2008Β Albany Capital made a loss after tax of Β£847,674Β (2007: Β£114,250). At the year-end, the net asset value per share for the Company was 49.4p.(2007: 51.1p)

The value ofΒ Albany's holdings in China Food Company and Sorbic International as ofΒ 30 September 2008Β was Β£10.2 million representing aΒ 21.4Β per cent gain onΒ Albany's original investment.

As atΒ 30 September 2008Β the Company had no debt and had cash balances in excess of Β£2.8 million.

Investing for Continued GrowthΒ 

AlbanyΒ has made significant progress since the Board successfully repositionedΒ Albany's investment strategy just over a year ago to concentrate on reversing China-based companies intoΒ AIMΒ listed cash shells, as stated in the Company's annual report for the year endedΒ 30 September 2007.

We are delighted with the progress the Company has made since December 2007 with the admission toΒ AIMΒ of China Food Company plc (AIM:Β CFC), a leading soya sauce producer, on 10 December 2007 and most recently the admission toΒ AIMΒ of Sorbic International plc (AIM: SORB), the third largest producer of sorbic acid and potassium sorbate - both key natural products used by food producers around the world, on 30 September 2008.

The successful repositioning of our investment strategy has resulted in acquiring significant holdings in twoΒ AIMΒ listed companies, both with leading positions in their respective markets.Β 

China Food Company and Sorbic International operate in markets which are forecast to grow and both companies are also benefiting from further additional investment in new production facilities. These are due to come on stream at both companies over the next twelve months, principally in order to meet the anticipated increases in demand in their respective markets. Both companies are therefore well positioned with strong management in place to deliver significant future growth.

Our focus over the last year has been to invest in companies which have a strong record in terms of profits growth and cash generation and both China Food Company and Sorbic International fulfil these criteria and both are also investing in the future.

Growing aspirations of emerging middle classes

Albany's strategy to focus on China-based investments continues to be endorsed by forecast economic trends inΒ China. Whilst we have seen inflationary pressures in that economy, which now look to have subsided from higher levels earlier in 2008, the directors believe our two investee companies are both set to benefit over the long term to a shift in domestic spend, primarily from a burgeoning 'middle-class'.

This segment of the consumer market inΒ ChinaΒ is expected to continue to grow over the next twenty years. In doing so it is expected to bring very significant influence to each of the consumer sectors, including food, particularly as household incomes increase and aspirational buying takes hold across a growing number of families benefiting from a move to urban living and improved income levels.

Research has highlighted the emergence of the Chinese urban middle classes and certainly reinforced our analysis that the spending power ofΒ China's emerging middle classes will soon redefine the Chinese market. Although producers of luxury goods may continue to cater only to the wealthiest households, other companies, especially manufacturers of mass consumer goods, can win the biggerΒ prize by broadening their focus to include the emerging middle class. It is exactly this segment of the market that both China Food Company, moving towards the premium brand end of the soya sauce market, and Sorbic International, set to benefit from the increased demand for more natural food preservatives, will benefit from.

In its Annual Chinese Consumer Survey 08, McKinsey & Company said that Chinese consumers earning above 5,000 renminbi per annum are more willing to pay a premium for the best products and adds that by 2015 these high earners will make up one-third of all urban consumers and account for half the value of all consumption.

ChinaΒ Investment Portfolio

Total investment

Β£8.4m

Opening fair value profit / (loss)

Nil

Fair value movement for the year

Β£1.8m

Market value at year end

Β£10.2m

Overall return

21.4%

China Food Company plc

OnΒ 6 December 2007, Vestpa Plc, anΒ AIMΒ listed cash shell whichΒ AlbanyΒ controlled, acquired Full Fortune Holdings Pte for a consideration of Β£25.17 million. The enlarged company, of whichΒ AlbanyΒ now own 19.9%, was renamed China Food Company Plc.

China Food Company plc is an established manufacturer of branded consumer condiment products and animal feeds based in the Shandong province of the People's Republic of China (the "PRC"), and announced interim results to 30 June 2008 with profit before tax of Β£3.54 million. (30 June 2007: Β£2.62 million).

Construction of the group's new Β£25 million, state-of-the-art facility inΒ ShouΒ GuangΒ City,Β Weifang,Β ShandongΒ province in theΒ PRC, is on track for completion in late 2008 and will significantly increase production capacity.

OnΒ 17 September 2008Β China Food Company reported strong first half revenue growth of 49.0 per cent year-on-year to Β£16.2 million (2007: Β£10.9 million) and gross profit growth of 15.0 per cent in a business climate of rising raw materials and distribution costs. Its condiments business continued to perform strongly producing revenue growth of 18.8% to Β£6.8 million (2007: Β£5.7 million) during the first half and its production facilities continued to operate at full capacity. China Food's animal feeds business also performed strongly growing revenues by 82.4% to Β£9.4 million (2007: Β£5.2 million).

It was very encouraging to see further progress with China Food'sΒ investment in the expansion of its distribution network and the range of brands which has been very successful, particularly in respect of its recently introduced premium brands. As a result, the Group's "Fushi" soya sauce brand has risen in the national rankings from 47thΒ place in 2007 to 9thΒ place in 2008. We believe that the company has substantial growth potential over the next 2 years as it seeks national distribution of its branded products.

Sorbic International plc

OnΒ 29 September 2008, Ninety Plc, anΒ AIMΒ listed cash shell whichΒ AlbanyΒ controlled, acquired Honour Field for a consideration of up to Β£20.12 million. The enlarged company, of whichΒ AlbanyΒ now own 38.7%, was renamed Sorbic International Plc.

Sorbic International plc is the 3rdΒ largest Sorbic Acid and Potassium Sorbate producer in the World and madeΒ PBTΒ Β£2.26 million at the half year toΒ 30 June 2008. Sorbic International has cash resources which will be used to double the production capacity (Sorbic is currently running at full capacity) to meet growing demand inΒ ChinaΒ and international clients (food and drink producers and pharma and cosmetic companies).

Sorbic International has three main elements to its future growth strategy: to increase current production capacity to meet demand, broaden the distribution and sales network and look at possible acquisitions or joint ventures.

The first of these strategic actions is already underway with work having already started on the investment into new facilities at Sorbic International's site inΒ LinyiΒ CityΒ in North East China. The existing facility has an area of approximately 33,000 mΒ² and has two production lines which are currently operating at their full design capacities. Sorbic has acquired land immediately adjacent to its present site with total area of approximately 14,700 mΒ². The total cost of expanding production facilities will be approximately Β£7.3 million whichΒ isΒ beingΒ financed by the company's existing cash resources. The proposed new production facilities will include two more production lines which would double the existing capacity. A major international food manufacturer has already expressed an interest in purchasing the entire output from one of the proposed new production lines.

The consideration of up to Β£20.12 million includes a sum payable under deferred consideration which will be paid if the company makes a profit before tax of RMB60 million (Β£4.9 million at an exchange rate of 12.2071 RMB to Β£1 at 30 September 2008) for the year ended 31 December 2008.

Non Core Portfolio

Total Investment

Β£5.0m

Opening fair value profit / (loss)

Β£(0.2)m

Fair value movement for the year

Β£(2.6)m

Market value at year end

Β£2.2m

Overall return

(56)%

The non core portfolio consists of holdings in Blue Oar Plc, Densitron Technologies Plc, Journey Group Plc and ZTC Plc. We are actively managing the non core portfolio in an effort to improve the overall market value of the portfolio. It is our intention to eventually dispose of non core holdings and close the portfolio.Β 

Profit and Loss account

Fee Income

Fee income, which represents transaction fees and corporate services provided to China Food Company Plc and Sorbic International Plc, increased to Β£419,065 for the year ended 30 September 2008 (2007: Β£20,000)

Β 

Operating expenses before share based payments

Operating expenses before share based payments increased to Β£878,453 for the year endedΒ 30 September 2008Β (2007: Β£367,360). The increase was in part due to the increased investment activity throughout the year.

Post balance sheet event regarding ZTC Plc

OnΒ 7 November 2008Β shares in ZTC Plc were suspended from trading onΒ AIMΒ due to a management control issue. As at 7 NovemberΒ AlbanyΒ Capital held 5.0 per cent of the issued ordinary shares in ZTC plc valued at Β£163,440 which is considered by the Board of Albany to be part of the Company's non-core portfolio. Subject to any notice of changeΒ AlbanyΒ would expect to recognise an impairment on this asset in the following financial year.Β 

Representative China Office -Β ShandongΒ Province

During the year the Company opened a representative office inΒ QingdaoΒ to focus on further investments inΒ ShandongΒ province, North Eastern China.Β ShandongΒ province has the second highest gross domestic product inΒ China.

Outlook

Since movingΒ AlbanyΒ onto a new investment strategy, the Company has established a dedicated investment portfolio with core holdings in companies with established trading records which are also very cash generative and well placed to benefit from future growth. Albany's core investments are on track to deliver further growth and it also remains well placed with the cash resources to make new investments, which the Company is actively seeking.

John McLean

Chairman

20 November 2008

IncomeΒ statement

for the year ended 30 September

2008

Β 

2007

Β£

Β 

Β£

(Losses)/gains on investments at fair value through profit or loss

(746,887)

Β 

164,729

Loss on disposal of loan notes

-

(314,999)

Investment income

33,000

18,150

Fee income

419,065

20,000

-----------------------------

-----------------------------

Total Revenue

(294,822)

(112,120)

-----------------------------

-----------------------------

Operating expenses before share based payments

(878,453)

(367,360)

Share based payments

(314,423)

(258,349)

-----------------------------

-----------------------------

Operating expenses

(1,192,876)

(625,709)

-----------------------------

-----------------------------

Operating loss

(1,487,698)

(737,829)

Finance income

447,073

723,264

-----------------------------

-----------------------------

Loss before tax

(1,040,625)

(14,565)

TaxationΒ 

192,951

(99,685)

-----------------------------

-----------------------------

LossΒ for the yearΒ 

(847,674)

(114,250)

==============

==============

Earnings per share:Β 

Basic and diluted

(2.69)

(0.39)

===============

==============

Β Β 

Balance sheet

as at 30 September

2008

Β 

2007

Β£

Β 

Β£

ASSETS

Non-current assets

Property, plant and equipment

8,831

4,592

Deferred tax

258,657

130,706

Investments in subsidiaries held at cost

-

1,739,000

-----------------------------

-----------------------

267,488

1,874,298

-----------------------------

-----------------------

Current assets

Financial assets at fair value through profit or loss

12,484,235

3,625,826

Trade and other receivables

292,663

284,858

Cash and cash equivalents

2,800,597

10,540,122

-----------------------------

-----------------------

15,577,495

14,450,806

-----------------------------

-----------------------

Total assets

15,844,983

16,325,104

===============

===========

LIABILITIES

Current liabilities

Trade and other payables

238,843

120,713

Current tax liabilities

-

65,000

-----------------------------

-----------------------

Total liabilities

238,843

185,713

-----------------------------

-----------------------

Net assets

15,606,140

16,139,391

===============

===========

EQUITY

Equity attributable to equity holders of the parent

Share capital

7,890,090

7,890,090

Share premium account

7,939,812

7,939,812

Shares to be issued

572,772

258,349

Retained (deficit) / earnings

(796,534)

51,140

-----------------------------

-----------------------

Total equity

15,606,140

16,139,391

==============

===========

The financial statements were approved by the Board of Directors and authorised for issue onΒ 19 NovemberΒ 2008Β and signed on their behalf.

Cash flow

for the year ended 30 September

2008

Β 

Β 

2007

Β£

Β 

Β 

Β£

Cash flows from operating activities

Cash used in operations

(562,256)

(329,753)

Purchase of investments held at fair value through profit and loss

(7,723,420)

(4,409,628)

Proceeds on sale of investments held at fair value through profit and loss

-

1,935,056

Interest received

521,502

509,253

Dividends received

33,000

18,150

Corporation taxes paid

-

(12,234)

-----------------------

---------------------

Net cash used in operating activities

(7,731,174)

(2,289,156)

-----------------------

--------------------

Cash flows from investing activities

Purchase of shares in subsidiary undertaking held at cost

-

Β 

(1,739,000)

Proceeds on sale of non-current available for sale investments

-

Β 

53,249

Purchase of property, plant and equipment

(8,351)

Β 

(6,652)

-----------------------

---------------------

Net cash used in investing activities

(8,351)

(1,692,403)

-----------------------

---------------------

Cash flows from financing activities

Proceeds from issue of share capital

-

Β 

12,271,667

Expense on share issues

-

Β 

(206,856)

-----------------------

---------------------

Net cash from financing activities

-

12,064,811

-----------------------

---------------------

Net (decrease) / increase in cash and cash equivalents

(7,739,525)

8,083,252

Cash and cash equivalents at beginning of year

10,540,122

2,456,870

-----------------------

---------------------

Cash and cash equivalents at end of year

2,800,597

10,540,122

===========

==========

Notes to the financial statements

1. Basis of preparation and general information

The figures for the year ended 30 September 2008 are un-audited and are not full financial statements. The figures for the years ended 30 September 2008 and 2007 do not constitute statutory accounts within the meaning of Section 240 (5) of the Companies Act 1985.Β The figures for the year ended 30 September 2007 are non-statutory and have been extracted from the financial statements filed with the Registrar of Companies which contain an unqualified audit report and no statements under Sections 237 (2) or 237 (3) of the Companies Act 1985.

Albany Capital plc ('Albany Capital') is the ultimate parent company. It is incorporated and domiciled inΒ Great Britain. The registered address of Albany Capital isΒ 17 Hanover Square,Β London,Β W1S 1HU. Its shares are listed onΒ AIMΒ of the London Stock Exchange.

The company's financial statements are for the twelve months endedΒ 30 September 2008. They have been prepared in accordance with International Financial Reporting Standards and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS as adopted for use in the European Union.Β 

The financial statements have been prepared under the historical cost convention except that they have been modified to include the revaluation of certain financial assets and liabilities. The measurement bases and principal accounting policies of the Company, which have been consistently applied to all periods, are set out below.Β 

Albany Capital Plc was a parent Company atΒ 30 September 2007Β and therefore prepared consolidated financial statements for the year then ended in accordance with United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). The date of transition to IFRS wasΒ 1 October 2006Β and therefore the comparative figures in these financial statements are based on Albany Capital Plc Company Information for the year endedΒ 30 September 2007, prepared under IFRS and stated for the first time. The comparative figures have been restated to reflect changes in accounting policies as a result of adoption of IFRS. The disclosures required by IFRS 1 concerning the transition from UK GAAP to IFRS are given in the reconciliation schedules, presented and explained in note 24. The Company has taken advantage of certain exemptions available under IFRSΒ 1 First-time adoption of International Financial Reporting Standards.

2. Investments

2008

2007

Β£

Β£

Non-currentΒ investments

Investments in subsidiaries held at cost

-

1,739,000

Current investments

Investments held at fair value through profit or loss

12,484,235

3,625,826

Included in the above isΒ Albany's investment in China Food Company Plc and Sorbic International Plc. Both transactions constituted a reverse takeover under theΒ AIMΒ Rules of a listed cash shell, Vestpa Plc in the instance of China Food Company Plc and Ninety Plc in the instance of Sorbic International Plc. Both Vestpa Plc and Ninety Plc were founded byΒ AlbanyΒ and listed asΒ AIMΒ shell companies with the intention of undertaking a reverse takeovers.

OnΒ 29 March 2007, Albany Capital subscribed for 50m ordinary shares of 0.1p each at par in Vestpa plc for a total cash consideration of Β£50,000. OnΒ 12 June 2007, Albany Capital subscribed for a further 168.9m ordinary shares at 1p each in Vestpa plc for a total cash consideration of Β£1,689,000. As atΒ 30 September 2007Β Albany Capital owned 59.16% of the Ordinary Share Capital of Vestpa plc whose principal activity was holding cash pending investment. When Albany Capital acquired a controlling interest in Vestpa plc no fair value adjustments were required to be made to the acquired balance sheet asset values.Β 

OnΒ 6 December 2007Β AlbanyΒ Capital ceased to controlΒ VestpaΒ plc due to a share subscriptionΒ by VestpaΒ plc to a third partyΒ reducingΒ Albany's interest in the company to 20%. On this date,Β VestpaΒ plc was renamed China Food Company plc.Β As of this date the investment was accounted for as an investment carried at fair value through profit or loss. No consideration on disposal was received by Albany Capital.Β 

As part of the subscription that took place onΒ 6 December 2008,Β Albany Capital subscribed for 7,807,500 shares at 30p each for a total consideration of Β£2,342,250. Additional market share purchases of Β£17,937 takeΒ Albany's total investment in China Food Company Plc to Β£4,099,187.Β AlbanyΒ has a total holding of 13,330,000 ordinary shares in China Food Company Plc.Β 

In September 2007Β Albany Capital subscribed for 55m ordinary shares of 0.1p each at par inΒ NinetyΒ plc for a total cash consideration of Β£55,000.Β OnΒ 24 OctoberΒ 2007, Albany Capital subscribed for a furtherΒ 209.5mΒ ordinary shares at 1p each inΒ NinetyΒ plc for a total cash consideration of Β£2,095,000. During the year Albany Capital increased its holding to 72% of the Ordinary Share Capital of Ninety plcΒ whose principal activity was holding cash pending investment.Β 

OnΒ 29 September 2008Β Albany Capital ceased to control Ninety plc due to a share subscriptionΒ byΒ Ninety plc to a third partyΒ reducingΒ Albany's interest in the company to 38.7%. On this date Ninety plc was renamed Sorbic International plc.Β As of this date the investment was accounted for as an investment carried at fair value through profit or loss. No consideration on disposal was received by Albany Capital. It should be noted that Albany Capital will see its interest in Sorbic International reduce to 26.7% subject to the issue of deferred shares which are conditional on Sorbic International Plc achieving a profit after tax of RMB 60 million (Β£4.38 million) for the year ending 31 December 2008.

As part of the subscription that took place onΒ 29 September 2008, Albany Capital subscribed for 4,444,444 shares at 45p each for a total consideration of Β£2,000,000. Additional market share purchases of Β£106,647Β takeΒ Albany's total investment in Sorbic International Plc toΒ Β£4,256,647.Β AlbanyΒ has a total holding of 8,987,778 ordinary shares in Sorbic International Plc.Β 

Basic and diluted earnings per share

2008

2007

Β£

Β£

Loss after taxΒ 

(847,674)

Β 

(114,250)

Weighted average number of shares

31,560,359

Β 

29,257,756

Basic and diluted earnings / (loss) per share (pence)

(2.69)

Β 

(0.39)

Net asset value per share

The group's undiluted basic net asset value per ordinary share is based on the net assets of the company at year end and on the weighted average number of shares for the year. There were no dilutive instruments in issue for all years. Reconciliations of the net asset value and weighted average number of shares used in the calculations are set out below.

2008

Β 2007

Β£

Β£

Net asset valueΒ 

15,606,140

Β 

16,139,391

Weighted average number of shares

31,560,359

Β 

29,257,756

Basic and diluted net asset value per share

49.45

Β 

55.16

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FR UKOWRWNRAAAA
Date   Source Headline
28th Aug 20194:41 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
28th Aug 20197:00 amRNSSecondary Trading following Cancellation
23rd Aug 20195:30 pmRNSAlbert Technologies
23rd Aug 201911:00 amRNSPrice Monitoring Extension
20th Aug 20192:05 pmRNSSecond Price Monitoring Extn
20th Aug 20192:00 pmRNSPrice Monitoring Extension
20th Aug 201910:30 amRNSResult of EGM and Cancellation
8th Aug 201911:06 amRNSSecond Price Monitoring Extn
8th Aug 201911:00 amRNSPrice Monitoring Extension
30th Jul 20192:30 pmRNSCorrection:Proposed Cancellation of trading on AIM
25th Jul 20194:38 pmRNSHolding(s) in Company
16th Jul 20197:00 amRNSProposed Cancellation of trading on AIM
24th Jun 20197:00 amRNSAnnual Financial Report
28th May 20194:41 pmRNSSecond Price Monitoring Extn
28th May 20194:36 pmRNSPrice Monitoring Extension
28th May 20197:00 amRNSUpdate on Trading
17th May 20197:00 amRNSExercise of Options
18th Apr 20197:00 amRNSExercise of Options and AIM Rule 17 Update
10th Apr 20191:09 pmRNSHolding(s) in Company
9th Apr 20198:18 amRNSHolding(s) in Company
26th Mar 20197:00 amRNSFinal Results
22nd Jan 20197:00 amRNSTrading Statement
10th Jan 201911:19 amRNSHolding(s) in Company
5th Dec 201810:43 amRNSResults of EGM
29th Nov 20183:47 pmRNSPDMR Shareholding
13th Nov 20187:00 amRNSNotice of EGM
29th Oct 201810:23 amRNSGrant of Options
23rd Oct 201812:00 pmRNSAlbert in Gartner's 2018 Magic Quadrant - Ad Tech
23rd Oct 20187:00 amRNSExercise of Options / Additional Listing
22nd Oct 20184:35 pmRNSPrice Monitoring Extension
22nd Oct 20182:10 pmRNSHolding(s) in Company
22nd Oct 20182:10 pmRNSHolding(s) in Company
27th Sep 20181:26 pmRNSPDMR Shareholding
26th Sep 201811:14 amRNSDirector/PCA Shareholding
24th Sep 20187:00 amRNSInterim Results
6th Sep 20182:57 pmRNSResult of AGM
31st Jul 20187:00 amRNSTrading Update, Board Changes & Notice of AGM
28th Jun 20187:00 amRNSHolding(s) in Company
27th Jun 20185:59 pmRNSPosting of Annual Report
27th Jun 20187:00 amRNSTR-1: Notification of major holdings
25th Jun 20182:51 pmRNSExercise of Options
22nd Jun 201811:03 amRNSResult of General Meeting
31st May 20181:15 pmRNSResult of Conditional Placing and Notice of GM
31st May 20187:01 amRNSProspective Directorate Change
31st May 20187:00 amRNSProposed conditional placing
15th May 20182:18 pmRNSExercise of Options
30th Apr 20187:00 amRNSAlbert Names Rob Norman as Advisory Board Member
24th Apr 20187:00 amRNSSignificant Pilot Projects
11th Apr 20187:00 amRNSChange of Nominated Advisor and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.